UNITEDHEALTH GROUP INC
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $447.6B | $400.3B | $371.6B | $324.2B | $287.6B |
| Operating income | $19.0B | $32.3B | $32.4B | $28.4B | $24.0B |
| Cash from operations | $19.7B | $24.2B | $29.1B | $26.2B | $22.3B |
| Capital expenditure | $3.6B | $3.5B | $3.4B | $2.8B | $2.5B |
| Free cash flow | $16.1B | $20.7B | $25.7B | $23.4B | $19.9B |
| Share repurchases | $5.5B | $9.0B | $8.0B | $7.0B | $5.0B |
| Impairments | $0 | $0 | $0 | $0 | $0 |
| Total assets | $309.6B | $298.3B | $273.7B | $245.7B | $212.2B |
| Total liabilities | $207.9B | $195.7B | $174.8B | $159.4B | $135.7B |
| Total debt | $77.7B | $76.2B | $61.5B | $56.8B | $44.6B |
Shares outstanding 908.1M · Free float 93.4%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- June 5, 2026 8-K
- May 11, 2026 8-K
- May 5, 2026 10-Q
- April 21, 2026 8-K
- March 9, 2026 8-K
- March 2, 2026 8-K
- March 2, 2026 10-K
- February 25, 2026 8-K